AAAAAA
Results:
1-24
|
Results: 24
Authors:
SCHUSTER A
BERNHARDT G
EIBLER E
BUSCHAUER A
HESSELINK W
Citation: A. Schuster et al., CHIRAL SEPARATION OF 3-PHENYL-3-(2-PYRIDYL)PROPYLAMINES, AND ANALOGOUS GUANIDINES AND GUANIDINE-N-CARBOXYLIC ACID-ESTERS WITH HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND CAPILLARY-ZONE-ELECTROPHORESIS, Journal of chromatography, 793(1), 1998, pp. 77-90
Authors:
SCHULZE FR
BUSCHAUER A
SCHUNACK W
Citation: Fr. Schulze et al., COMBINED HISTAMINE H-1 H-2 RECEPTOR ANTAGONISTS - PART-I - PHARMACOLOGICAL HYBRIDS WITH PHENIRAMINE-LIKE AND ROXATIDINE-LIKE SUBSTRUCTURES/, European journal of pharmaceutical sciences, 6(3), 1998, pp. 177-186
Authors:
WOLF C
SCHULZE FR
BUSCHAUER A
SCHUNACK W
Citation: C. Wolf et al., COMBINED HISTAMINE H-1 H-2 RECEPTOR ANTAGONISTS - PART-II - PHARMACOLOGICAL HYBRIDS WITH PHENIRAMINE-LIKE AND TIOTIDINE-LIKE SUBSTRUCTURES/, European journal of pharmaceutical sciences, 6(3), 1998, pp. 187-196
Authors:
MUCKENSCHNABEL I
BERNHARDT C
SPRUSS T
DIETL B
BUSCHAUER A
Citation: I. Muckenschnabel et al., QUANTITATION OF HYALURONIDASES BY THE MORGAN-ELSON REACTION - COMPARISON OF THE ENZYME-ACTIVITIES IN THE PLASMA OF TUMOR PATIENTS AND HEALTHY-VOLUNTEERS, Cancer letters, 131(1), 1998, pp. 13-20
Authors:
MUCKENSCHNABEL I
BERNHARDT G
SPRUSS T
BUSCHAUER A
Citation: I. Muckenschnabel et al., PHARMACOKINETICS AND TISSUE DISTRIBUTION OF BOVINE TESTICULAR HYALURONIDASE AND VINBLASTINE IN MICE - AN ATTEMPT TO OPTIMIZE THE MODE OF ADJUVANT HYALURONIDASE ADMINISTRATION IN CANCER-CHEMOTHERAPY, Cancer letters, 131(1), 1998, pp. 71-84
Authors:
AIGLSTORFER I
UFFRECHT A
GESSELE K
MOSER C
SCHUSTER A
MERZ S
MALAWSKA B
BERNHARDT G
DOVE S
BUSCHAUER A
Citation: I. Aiglstorfer et al., NPY Y-1 ANTAGONISTS - STRUCTURE-ACTIVITY-RELATIONSHIPS OF ARGININE DERIVATIVES AND HYBRID COMPOUNDS WITH ARPROMIDINE-LIKE PARTIAL STRUCTURES, Regulatory peptides, 75-6, 1998, pp. 9-21
Authors:
DOVE S
BUSCHAUER A
Citation: S. Dove et A. Buschauer, QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS AND POSSIBLE RECEPTOR-BINDING OF HISTAMINE H-2 AGONISTIC IMIDAZOLYLPROPYLGUANIDINES, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 115-115
Authors:
BERNHARDT G
MUCKENSCHNABEL I
SPRUSS T
BUSCHAUER A
Citation: G. Bernhardt et al., PRECLINICAL TUMORPHARMACOLOGICAL AND PHARMACOKINETIC STUDIES ON THE ADJUVANT ADMINISTRATION OF HYALURONIDASE IN THE CHEMOTHERAPY OF MALIGNANT-MELANOMA, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 458-458
Authors:
DOVE S
BUSCHAUER A
Citation: S. Dove et A. Buschauer, QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS AND POSSIBLE RECEPTOR-BINDING OF HISTAMINE H-2 AGONISTIC IMIDAZOLYLPROPYLGUANIDINES, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 929-929
Authors:
MEISTER A
BERNHARDT G
BUSCHAUER A
Citation: A. Meister et al., PHARMACOLOGY OF COTRANSMISSION IN THE ELECTRICALLY STIMULATED ISOLATED RAT DUCTUS DEFERENS NERVE-MUSCLE PREPARATION, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 37128-37128
Authors:
DOVE S
BUSCHAUER A
Citation: S. Dove et A. Buschauer, STEPWISE LEAVE-ONE-ISOMER-OUT FREE-WILSON APPROACHES AS PREPROCESSINGTOOLS IN QSAR ANALYSIS OF RACEMATES, Quantitative structure-activity relationships, 16(1), 1997, pp. 11-19
Authors:
MUCKENSCHNABEL I
BERNHARDT G
SPRUSS T
BUSCHAUER A
Citation: I. Muckenschnabel et al., A VERSATILE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY METHOD FOR THE MEASUREMENT OF MELPHALAN TAILORED TO THE OPTIMIZATION OF HYPERTHERMIC ISOLATED LIMB PERFUSION, European journal of pharmaceutical sciences, 5(3), 1997, pp. 129-137
Authors:
SCHUSTER A
BERNHARDT G
BUSCHAUER A
Citation: A. Schuster et al., DETERMINATION OF THE ARPROMIDINE-TYPE HISTAMINE H-2-RECEPTOR AGONIST )PROPYL]-N-2-[3-(1H-IMIDAZOL-4-YL)PROPYL]GUANIDINE AND CORRESPONDING N-3-ALKOXYCARBONYLGUANIDINES BY HPLC AND CE1, European journal of pharmaceutical sciences, 5(2), 1997, pp. 79-88
Authors:
MULLER M
KNIEPS S
GESSELE K
DOVE S
BERNHARDT G
BUSCHAUER A
Citation: M. Muller et al., SYNTHESIS AND NEUROPEPTIDE-Y Y-1 RECEPTOR ANTAGONISTIC ACTIVITY OF N,N-DISUBSTITUTED OMEGA-GUANIDINOIC AND OMEGA-AMINOALKIANOIC ACID-AMIDES, Archiv der pharmazie, 330(11), 1997, pp. 333-342
Authors:
WEISS T
BERNHARDT G
BUSCHAUER A
JAUCH KW
ZIRNGIBL H
Citation: T. Weiss et al., HIGH-RESOLUTION REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHYANALYSIS OF POLYAMINES AND THEIR MONOACETYL CONJUGATES BY FLUORESCENCE DETECTION AFTER DERIVATIZATION WITH N-HYDROXYSUCCINIMIDYL 6-QUINOLINYL CARBAMATE, Analytical biochemistry, 247(2), 1997, pp. 294-304
Authors:
MUCKENSCHNABEL I
BERNHARDT G
SPRUSS T
BUSCHAUER A
Citation: I. Muckenschnabel et al., HYALURONIDASE PRETREATMENT PRODUCES SELECTIVE MELPHALAN ENRICHMENT INMALIGNANT-MELANOMA IMPLANTED IN NUDE-MICE, Cancer chemotherapy and pharmacology, 38(1), 1996, pp. 88-94
Authors:
KNIEPS S
MICHEL MC
DOVE S
BUSCHAUER A
Citation: S. Knieps et al., NONPEPTIDE NEUROPEPTIDE-Y ANTAGONISTS FROM THE HISTAMINE H-2 AGONIST ARPROMEDINE - ROLE OF THE GUANIDINE GROUP, Bioorganic & medicinal chemistry letters, 5(18), 1995, pp. 2065-2070
Authors:
BUSCHAUER A
MOHR R
SCHUNACK W
Citation: A. Buschauer et al., SYNTHESIS AND HISTAMINE H-2-RECEPTOR ANTAGONIST ACTIVITY OF 4-(1-PYRAZOLYL)BUTANAMIDES, GUANIDINOPYRAZOLES, AND RELATED-COMPOUNDS, Archiv der pharmazie, 328(4), 1995, pp. 349-358
Authors:
GLASS D
BUSCHAUER A
TENOR H
BARTEL S
WILLSHAHAB L
KRAUSE EG
Citation: D. Glass et al., 4-(4-GUANIDINOBENZOYL)-2-IMIDAZOLONES AND RELATED-COMPOUNDS - PHOSPHODIESTERASE INHIBITORS AND NOVEL CARDIOTONICS WITH COMBINED HISTAMINE H-2-RECEPTOR AGONIST AND PDE-III INHIBITOR ACTIVITY, Archiv der pharmazie, 328(10), 1995, pp. 709-719
Authors:
HAGELUKEN A
BURDE R
NURNBERG B
HARHAMMER R
BUSCHAUER A
SEIFERT R
Citation: A. Hageluken et al., CATIONIC AMPHIPHILIC ARPROMIDINE-DERIVED GUANIDINES AND A HISTAMINE TRIFLUOROMETHYL-TOLUIDIDE DERIVATIVE MAY ACTIVATE PERTUSSIS-TOXIN-SENSITIVE G-PROTEINS BY A RECEPTOR-INDEPENDENT MECHANISM, Naunyn-Schmiedeberg's archives of pharmacology, 351(3), 1995, pp. 305-308
Authors:
FELIX SB
BUSCHAUER A
BAUMANN G
Citation: Sb. Felix et al., HEMODYNAMIC PROFILE OF NEW H-2-RECEPTOR AGONISTS IN CONGESTIVE-HEART-FAILURE, European journal of clinical investigation, 25, 1995, pp. 42-46
Authors:
RIXEN D
NEUGEBAUER E
LECHLEUTHNER A
BUSCHAUER A
NAGELSCHMIDT M
THOMA S
RINK A
Citation: D. Rixen et al., BENEFICIAL EFFECT OF H-2-AGONISM AND H-1-ANTAGONISM IN RAT ENDOTOXIC-SHOCK, Shock, 2(1), 1994, pp. 47-52
Authors:
SCHULZE FR
ALISCH RA
BUSCHAUER A
SCHUNACK W
Citation: Fr. Schulze et al., SYNTHESIS AND COMBINED HISTAMINE H1-RECEP TOR AND H2-RECEPTOR ANTAGONIST ACTIVITY OF MEPYRAMINE, PHENIRAMINE, AND CYCLIZINE DERIVATIVES WITH CYANOGUANIDINE, UREA, AND NITROETHENEDIAMINE GROUPS, Archiv der pharmazie, 327(7), 1994, pp. 455-462
Authors:
KLEINETEBBE J
JOSTIES C
FRANK G
STALLEICKEN D
BUSCHAUER A
SCHUNACK W
KUNKEL G
CZARNETZKI B
Citation: J. Kleinetebbe et al., INHIBITION OF IGE-MEDIATED AND NON-IGE-MEDIATED HISTAMINE-RELEASE FROM HUMAN BASOPHIL LEUKOCYTES IN-VITRO BY A HISTAMINE H-1-ANTAGONIST, DESETHOXYCARBONYL-LORATADINE, Journal of allergy and clinical immunology, 93(2), 1994, pp. 494-500
Risultati:
1-24
|